Ryan White HIV/AIDS Program Parts A and B Integrated HIV Planning Implementation Cooperative Agreement to John Snow, Inc. (JSI), U69HA30144, 28431 [2018-13121]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 118 / Tuesday, June 19, 2018 / Notices
28431
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB
control No.
Title of collection
Infant Formula Requirements ..................................................................................................................................
Premarket Notification for a New Dietary Ingredient ...............................................................................................
Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring ..............................................
Guidance for Industry: Formal Dispute Resolution; Scientific and Technical Issues Related to Pharmaceutical
Current Good Manufacturing Practice .................................................................................................................
Requests for Inspection by an Accredited Person Under the Inspection for Accredited Persons Program ..........
Substances Prohibited from Use in Animal Food or Feed .....................................................................................
Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under
21 CFR 884.5300 .................................................................................................................................................
Guidance for Industry: Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements
During an Influenza Pandemic .............................................................................................................................
Guidance on Consultation Procedures: Foods Derived From New Plant Varieties ...............................................
Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices ......................
Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard
Menu Items in Restaurants and Similar Retail Food Establishments .................................................................
Guidance for Industry, Researchers, Patient Groups, and Food and Drug Administration Staff on Meetings with
the Office of Orphan Products Development .......................................................................................................
Food Allergen Labeling and Reporting ....................................................................................................................
Transfer of a Premarket Notification Clearance ......................................................................................................
Dated: June 13, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–13098 Filed 6–18–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Ryan White HIV/AIDS Program Parts A
and B Integrated HIV Planning
Implementation Cooperative
Agreement to John Snow, Inc. (JSI),
U69HA30144
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice of non-competitive FY
2018 supplemental award.
AGENCY:
This noncompetitive
supplement award to JSI will support
and strengthen current Ryan White HIV/
AIDS Program (RWHAP) Part A and Part
B priority setting and resource
allocation processes to ensure people
living with HIV are linked to care,
remain engaged in care, and achieve
viral suppression.
FOR FURTHER INFORMATION CONTACT: Dr.
Rene Sterling, Acting Director, Division
of State HIV/AIDS Programs, HIV/AIDS
Bureau, HRSA; 5600 Fishers Lane,
Room 09W50, Rockville, MD 20857;
Phone: (301) 443–9017, Email:
rsterling@hrsa.gov.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: JSI
(U69HA30144).
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:55 Jun 18, 2018
Jkt 244001
Amount of Non-Competitive Award:
$300,000 in FY 2018.
Period of Funding: July 1, 2018,
through June 30, 2019.
CFDA Number: No. 93.145.
Authority: Sections 2606 and 2654(b)
of the Public Health Service Act, as
amended by the Ryan White HIV/AIDS
Treatment Extension Act of 2009 (Pub.
L. 111–87).
Justification: In 2016, JSI was awarded
a 3-year cooperative agreement under
HRSA–16–082 RWHAP Integrated HIV
Planning Implementation (CFDA
93.145), authorized by Sections 2606
and 2654(b) of the Public Health Service
Act, as amended by the Ryan White
HIV/AIDS Treatment Extension Act of
2009 (Pub. L. 111–87). The cooperative
agreement was established to provide
technical assistance to RWHAP Parts A
and B recipients and their planning
bodies regarding: (1) The integration of
HIV planning across prevention, care,
and treatment service delivery systems;
and (2) the development,
implementation, monitoring, and
evaluation of Integrated HIV Prevention
and Care Plans. RWHAP Parts A and B
recipients and planning bodies use
Integrated Plans to better inform and
coordinate HIV prevention and care
program planning, resource allocation,
and continuous quality improvement
efforts to meet the HIV service delivery
needs within their jurisdictions.
The proposed supplemental funding
will provide RWHAP Parts A and B
recipients with additional technical
assistance (TA) specifically focused on
resource allocation planning and
implementation. These additional TA
activities will build upon data elements
identified in the Integrated Plan and
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Date
approval
expires
0910–0256
0910–0330
0910–0409
5/31/2021
5/31/2021
5/31/2021
0910–0563
0910–0569
0910–0627
5/31/2021
5/31/2021
5/31/2021
0910–0633
5/31/2021
0910–0701
0910–0704
0910–0741
5/31/2021
5/31/2021
5/31/2021
0910–0782
5/31/2021
0910–0787
0910–0792
0910–0852
5/31/2021
5/31/2021
5/31/2021
provide jurisdictions with strategies,
tools, and resources to effectively
allocate annual available resources to
prioritize HIV unmet needs. The TA
activities will be directed at addressing
more efficient and proactive methods in
the Priority Setting and Resource
Allocation (PSRA) process to increase
the ability of health care providers and
systems to ensure people living with
HIV are linked to care, remain engaged
in care, and achieve HIV viral
suppression.
Dated: June 12, 2018.
George Sigounas,
Administrator.
[FR Doc. 2018–13121 Filed 6–18–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 83, Number 118 (Tuesday, June 19, 2018)]
[Notices]
[Page 28431]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13121]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Ryan White HIV/AIDS Program Parts A and B Integrated HIV Planning
Implementation Cooperative Agreement to John Snow, Inc. (JSI),
U69HA30144
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice of non-competitive FY 2018 supplemental award.
-----------------------------------------------------------------------
SUMMARY: This noncompetitive supplement award to JSI will support and
strengthen current Ryan White HIV/AIDS Program (RWHAP) Part A and Part
B priority setting and resource allocation processes to ensure people
living with HIV are linked to care, remain engaged in care, and achieve
viral suppression.
FOR FURTHER INFORMATION CONTACT: Dr. Rene Sterling, Acting Director,
Division of State HIV/AIDS Programs, HIV/AIDS Bureau, HRSA; 5600
Fishers Lane, Room 09W50, Rockville, MD 20857; Phone: (301) 443-9017,
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: JSI (U69HA30144).
Amount of Non-Competitive Award: $300,000 in FY 2018.
Period of Funding: July 1, 2018, through June 30, 2019.
CFDA Number: No. 93.145.
Authority: Sections 2606 and 2654(b) of the Public Health Service
Act, as amended by the Ryan White HIV/AIDS Treatment Extension Act of
2009 (Pub. L. 111-87).
Justification: In 2016, JSI was awarded a 3-year cooperative
agreement under HRSA-16-082 RWHAP Integrated HIV Planning
Implementation (CFDA 93.145), authorized by Sections 2606 and 2654(b)
of the Public Health Service Act, as amended by the Ryan White HIV/AIDS
Treatment Extension Act of 2009 (Pub. L. 111-87). The cooperative
agreement was established to provide technical assistance to RWHAP
Parts A and B recipients and their planning bodies regarding: (1) The
integration of HIV planning across prevention, care, and treatment
service delivery systems; and (2) the development, implementation,
monitoring, and evaluation of Integrated HIV Prevention and Care Plans.
RWHAP Parts A and B recipients and planning bodies use Integrated Plans
to better inform and coordinate HIV prevention and care program
planning, resource allocation, and continuous quality improvement
efforts to meet the HIV service delivery needs within their
jurisdictions.
The proposed supplemental funding will provide RWHAP Parts A and B
recipients with additional technical assistance (TA) specifically
focused on resource allocation planning and implementation. These
additional TA activities will build upon data elements identified in
the Integrated Plan and provide jurisdictions with strategies, tools,
and resources to effectively allocate annual available resources to
prioritize HIV unmet needs. The TA activities will be directed at
addressing more efficient and proactive methods in the Priority Setting
and Resource Allocation (PSRA) process to increase the ability of
health care providers and systems to ensure people living with HIV are
linked to care, remain engaged in care, and achieve HIV viral
suppression.
Dated: June 12, 2018.
George Sigounas,
Administrator.
[FR Doc. 2018-13121 Filed 6-18-18; 8:45 am]
BILLING CODE 4165-15-P
